Special Interview with Prof. Jochen Christoph Walz

On January 20, 2025, the Editorial Office of Mini-invasive Surgery (MIS) had the privilege of interviewing Prof. Jochen Christoph Walz, from the Institut Paoli-Calmettes, Marseille, France.

Prof. Walz is a leading expert in the field of urological imaging, particularly renowned for his pioneering research in prostate cancer imaging, diagnosis, predictive tools, life expectancy assessments, surgical treatments, and minimally invasive surgery. His innovative work has significantly advanced relevant technologies and played a pivotal role in enhancing patient outcomes and prognostic evaluations.

Here are the details of the interview:

Q1. You have conducted extensive research on imaging techniques in prostate cancer. How do you see the role of cutting-edge imaging technologies, such as PSMA-PET, evolving in prostate cancer diagnosis and management?

Q2. Minimally invasive surgical techniques are transforming urology. What advancements in robotic-assisted prostate surgery do you find most promising, and where do you see room for improvement?

Q3. What do you see as the next big breakthrough in prostate cancer research?

Q4. If you could initiate one global initiative to improve prostate cancer outcomes, what would it focus on?

Q5. As a Co-Editor-in-Chief of European Urology Open Science, do you have any constructive suggestions for journal management?

Profile:

Institut Paoli-Calmettes, Marseille, France.

Prof. Walz is an Associate Professor of Urology and the Chair of the Department of Urology at the prestigious Paoli-Calmettes Cancer Center in Marseille, France. He is an internationally recognized authority in the field of urological imaging, with specialized expertise in prostate cancer imaging and diagnosis, predictive tools, life expectancy assessments, surgical treatments, and minimally invasive surgery.

As Co-Editor-in-Chief of European Urology Open Science, Prof. Walz plays a pivotal role in advancing urological research and clinical practice. He also serves as President of the Urological Imaging Section of the European Association of Urology (ESUI), contributing to significant progress in urological oncology.

Throughout his distinguished career, Prof. Walz has consistently demonstrated excellence in both academic research and clinical practice, particularly in urological tumors. His groundbreaking contributions are shaping the future of urological care, offering hope and improved patient outcomes worldwide.

Editor: Ivy Wang
Language Editor: Emma Chen
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Mini-invasive Surgery